Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($) $ in Thousands	Total	Common shares	Treasury Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income / (Loss)	Accumulated Deficit
Balance, beginning of period (in shares) at Jun. 30, 2022		18,247,000
Balance, beginning of period at Jun. 30, 2022	$ 113,459	$ 2	$ (3,406)	$ 197,785	$ (4,562)	$ (76,360)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	15,793					15,793
Foreign currency translation adjustments	(1,123)				(1,123)
Changes in fair value of cash flow hedges	$ 553				553
Purchase of treasury shares (in shares)	(17,558)	(18,000)
Purchase of treasury shares	$ (276)		(276)
Provision for common stock warrants	596			596
Issue of common shares (in shares)		69,000
Issuance of common shares	1,209			1,209
Share-based compensation expense	1,512			1,512
Balance, end of period (in shares) at Dec. 31, 2022		18,298,000
Balance, end of period at Dec. 31, 2022	131,723	$ 2	(3,682)	201,102	(5,132)	(60,567)
Balance, beginning of period (in shares) at Sep. 30, 2022		18,230,000
Balance, beginning of period at Sep. 30, 2022	118,881	$ 2	(3,682)	198,898	(6,500)	(69,837)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	9,270					9,270
Foreign currency translation adjustments	554				554
Changes in fair value of cash flow hedges	814				814
Provision for common stock warrants	310			310
Issue of common shares (in shares)		68,000
Issuance of common shares	1,188			1,188
Share-based compensation expense	706			706
Balance, end of period (in shares) at Dec. 31, 2022		18,298,000
Balance, end of period at Dec. 31, 2022	$ 131,723	$ 2	(3,682)	201,102	(5,132)	(60,567)
Balance, beginning of period (in shares) at Jun. 30, 2023	18,280,419	18,280,000
Balance, beginning of period at Jun. 30, 2023	$ 149,964	$ 2	(3,682)	204,734	(6,312)	(44,778)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	13,500					13,500
Foreign currency translation adjustments	(22)				(22)
Changes in fair value of cash flow hedges	$ 201				201
Purchase of treasury shares (in shares)	(623,327)	(623,000)
Purchase of treasury shares	$ (10,434)		(10,434)
Provision for common stock warrants	594			594
Issue of common shares (in shares)		24,000
Issuance of common shares	11			11
Share-based compensation expense	$ 2,299			2,299
Balance, end of period (in shares) at Dec. 31, 2023	17,681,035	17,681,000
Balance, end of period at Dec. 31, 2023	$ 156,113	$ 2	(14,116)	207,638	(6,133)	(31,278)
Balance, beginning of period (in shares) at Sep. 30, 2023		18,169,000
Balance, beginning of period at Sep. 30, 2023	156,039	$ 2	(5,726)	206,323	(7,207)	(37,353)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	6,075					6,075
Foreign currency translation adjustments	679				679
Changes in fair value of cash flow hedges	$ 395				395
Purchase of treasury shares (in shares)	(488,803)	(489,000)
Purchase of treasury shares	$ (8,390)		(8,390)
Provision for common stock warrants	307			307
Issue of common shares (in shares)		1,000
Issuance of common shares	6			6
Share-based compensation expense	$ 1,002			1,002
Balance, end of period (in shares) at Dec. 31, 2023	17,681,035	17,681,000
Balance, end of period at Dec. 31, 2023	$ 156,113	$ 2	$ (14,116)	$ 207,638	$ (6,133)	$ (31,278)